NASDAQ:DFBHU - DFB Healthcare Acquisitions Stock Price, News, & Analysis

$10.53
-0.07 (-0.66 %)
(As of 07/22/2019 08:18 AM ET)
eye icon Add
Today's Range
$10.53
Now: $10.53
$10.53
50-Day Range
$10.30
MA: $10.47
$10.77
52-Week Range
$10.10
Now: $10.53
$10.77
Volume420 shs
Average Volume34,888 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
DFB Healthcare Acquisitions Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:DFBHU
CUSIPN/A
CIKN/A
WebN/A
Phone+1-917-3593042

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive DFBHU News and Ratings via Email

Sign-up to receive the latest news and ratings for DFBHU and its competitors with MarketBeat's FREE daily newsletter.

DFB Healthcare Acquisitions (NASDAQ:DFBHU) Frequently Asked Questions

What is DFB Healthcare Acquisitions' stock symbol?

DFB Healthcare Acquisitions trades on the NASDAQ under the ticker symbol "DFBHU."

Has DFB Healthcare Acquisitions been receiving favorable news coverage?

Media stories about DFBHU stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. DFB Healthcare Acquisitions earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for DFB Healthcare Acquisitions.

What other stocks do shareholders of DFB Healthcare Acquisitions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DFB Healthcare Acquisitions investors own include AGNC Investment (AGNC), Adamis Pharmaceuticals (ADMP), MAXIMUS (MMS), Aquabounty Technologies (AQB), American River Bankshares (AMRB), Pagegroup (PAGE), EVRAZ (EVR), DP Eurasia (DPEU), Derwent London (DLN) and Amigo (AMGO).

When did DFB Healthcare Acquisitions IPO?

(DFBHU) raised $250 million in an initial public offering on Friday, February 16th 2018. The company issued 25,000,000 shares at a price of $10.00 per share. Goldman Sachs and Deutsche Bank Securities acted as the underwriters for the IPO and Leerink Partners was co-manager.

How do I buy shares of DFB Healthcare Acquisitions?

Shares of DFBHU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is DFB Healthcare Acquisitions' stock price today?

One share of DFBHU stock can currently be purchased for approximately $10.53.

How can I contact DFB Healthcare Acquisitions?

DFB Healthcare Acquisitions' mailing address is 300 Central Park W, NEW YORK, NY 10024-1513, United States. The company can be reached via phone at +1-917-3593042.


MarketBeat Community Rating for DFB Healthcare Acquisitions (NASDAQ DFBHU)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  79 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  164
MarketBeat's community ratings are surveys of what our community members think about DFB Healthcare Acquisitions and other stocks. Vote "Outperform" if you believe DFBHU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DFBHU will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel